SMARCA1 and cancer: Western blotting confirmed the dramatic reduction of SLC7A11 in SNF2L-deficient MDA-MB-231 cells (Fig. 4D, uncropped original western blots Fig. 4D), indicating the role of SNF2L in regulating SLC7A11 levels in cancer cells.